EUR 156.14
(0.21%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 922.95 Million | -1.58 Billion | 10.73 Billion | 3 Billion | -80.59 Million |
Net Income | 94.87 Million | -2.62 Billion | 3.62 Billion | 322.31 Million | -30.38 Million |
Depreciation & Amortization | 139.64 Million | 154.06 Million | 63.65 Million | 30.96 Million | 16.87 Million |
Deferred income taxes | -216.33 Million | -468.03 Million | -558.32 Million | 474 Thousand | -20.9 Million |
Stock-based compensation | 864.71 Million | 1.56 Billion | 820.68 Million | 70.54 Million | 31.14 Million |
Change in working capital | 326.2 Million | -1.03 Billion | 6.83 Billion | 2.61 Billion | -100.31 Million |
Other non-cash items | -286.14 Million | 819.12 Million | -53.39 Million | -37.13 Million | 22.98 Million |
Investing Cash Flow | 5.39 Million | -663.82 Million | -1.12 Billion | 50.82 Million | -105.35 Million |
Investments in PPE | -63.2 Million | -63.97 Million | -85.78 Million | -18.8 Million | -40.47 Million |
Acquisitions | -30.73 Million | -186.15 Million | -70.91 Million | 33.61 Million | -5.69 Million |
Investment purchases | -332.52 Million | -1.46 Billion | -3.33 Billion | -538.4 Million | -279.2 Million |
Sales/Maturities of investments | 461.32 Million | 970.73 Million | 2.57 Billion | 574.41 Million | 273.11 Million |
Other Investing Activities | -29.47 Million | 78.64 Million | -211.63 Million | 46.03 Million | -53.09 Million |
Financing Cash Flow | -811.33 Million | -5.83 Billion | 3.28 Billion | 18.8 Million | -16.6 Million |
Debt repayment | -355.65 Million | -191.07 Million | -3.39 Billion | - | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | -277.79 Million | -351.86 Million | -262.79 Million | -1.93 Million | -20.95 Million |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | -455.67 Million | -5.64 Billion | 3.28 Billion | 18.8 Million | -16.6 Million |
Accounts receivables | 80.37 Million | -141.02 Million | 28.51 Million | -157.15 Million | 30.7 Million |
Accounts payables | - | 18.61 Million | 27.33 Million | 6.09 Million | -2.38 Million |
Inventory | - | - | -28.51 Million | -6.09 Million | 3.4 Million |
Other working capital | 245.83 Million | -909.03 Million | 6.8 Billion | 2.77 Billion | -132.03 Million |
Cash at beginning of period | 9.42 Billion | 17.68 Billion | 4.85 Billion | 1.78 Billion | 1.98 Billion |
Cash at end of period | 9.55 Billion | 9.42 Billion | 17.68 Billion | 4.85 Billion | 1.78 Billion |
Capital Expenditure | -63.2 Million | -63.97 Million | -85.78 Million | -18.8 Million | -40.47 Million |
Effect of forex changes on cash | 8.77 Million | -163.25 Million | -64.88 Million | -2.08 Million | -170 Thousand |
Net cash flow / Change in cash | 125.78 Million | -8.25 Billion | 12.82 Billion | 3.07 Billion | -202.72 Million |
Free Cash Flow | 859.74 Million | -1.64 Billion | 10.64 Billion | 2.98 Billion | -121.06 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 75.49 Million | 36.15 Million | 1.17 Billion | 273.43 Million | 94.87 Million | -2.26 Million |
Depreciation & Amortization | 30.69 Million | 34.5 Million | 29.32 Million | 29.48 Million | 139.64 Million | 31.96 Million |
Deferred income taxes | -22.88 Million | -130.4 Million | 214.36 Million | -166.11 Million | -216.33 Million | 21.21 Million |
Stock-based compensation | 248.41 Million | 217.93 Million | 224.5 Million | 163.88 Million | 864.71 Million | 218.15 Million |
Change in working capital | 245.01 Million | -93.63 Million | -474 Million | -188.34 Million | 326.2 Million | 187.7 Million |
Other non-cash items | 119.8 Million | 66.84 Million | -18.22 Million | -117.53 Million | -286.14 Million | -142.84 Million |
Investing Cash Flow | -88.67 Million | -18.61 Million | -125.68 Million | 90.5 Million | 5.39 Million | -72.36 Million |
Investments in PPE | - | - | - | -11.03 Million | -63.2 Million | -21.2 Million |
Acquisitions | - | - | - | 11.03 Million | -30.73 Million | -20.87 Million |
Investment purchases | -18.48 Million | 135 Thousand | -135 Thousand | -129.9 Million | -332.52 Million | -55.41 Million |
Sales/Maturities of investments | 161 Thousand | 766 Thousand | 51.65 Million | 193.01 Million | 461.32 Million | 79.14 Million |
Other Investing Activities | -70.35 Million | -19.51 Million | -177.2 Million | 27.39 Million | -29.47 Million | -54.01 Million |
Financing Cash Flow | -311.32 Million | -933.73 Million | 1.92 Billion | 922.79 Million | -811.33 Million | -591.86 Million |
Debt repayment | - | - | -1.24 Billion | -80.86 Million | -355.65 Million | -177.19 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -117.22 Million | -93.83 Million | -277.79 Million | -68.57 Million |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -311.32 Million | -953.57 Million | 632.02 Million | 1 Billion | -455.67 Million | -414.67 Million |
Accounts receivables | - | 39.02 Million | -108.8 Million | -942 Thousand | 80.37 Million | 117.89 Million |
Accounts payables | - | - | - | - | - | 9.75 Million |
Inventory | - | - | - | - | - | -117.89 Million |
Other working capital | 245.01 Million | -609.24 Million | 41.61 Million | -187.4 Million | 245.83 Million | 60.06 Million |
Cash at beginning of period | 11.27 Billion | 11.74 Billion | 9.55 Billion | 8.51 Billion | 9.42 Billion | 8.88 Billion |
Cash at end of period | 11.61 Billion | 11.27 Billion | 11.74 Billion | 9.55 Billion | 9.55 Billion | 8.51 Billion |
Capital Expenditure | - | - | - | -11.03 Million | -63.2 Million | -21.2 Million |
Effect of forex changes on cash | 45.58 Million | -4.73 Million | -21.18 Million | 36.12 Million | 8.77 Million | -22.98 Million |
Net cash flow / Change in cash | 342.12 Million | -472.9 Million | 2.19 Billion | 1.04 Billion | 125.78 Million | -373.27 Million |
Free Cash Flow | 696.54 Million | 484.19 Million | 411.48 Million | -16.21 Million | 859.74 Million | 292.73 Million |
NCB
DWF
000938
TIPSINDLTD
DSCV
TRRPF